Floatz logo

Colon Kcc Heptapeptide

Inflammatory Bowel Disease (IBD)

Danielle Kim Turgeonprotein_peptidePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Inflammatory Bowel Disease (IBD) cohort.

Asset / SponsorPhaseRating
MACROGOLS
Region Skane
Phase 4A
Prucalopride
Region Skane
Phase 4BBB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Cedars-Sinai Medical Center
Phase 4BBB
Epinephrine
Cedars-Sinai Medical Center
Phase 4BB
DEXAMETHASONE
Cedars-Sinai Medical Center
Phase 4BB

View all 31 →

Same molecule, other indications

Colon Kcc Heptapeptide is also rated in:

polyp of colonDormant
CC
Indicative ·
47 / 100
View asset →
colorectal cancerDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →